Lewis Bioserch Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
- Paid Up Capital ₹ 0.30 M
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
- Revenue Growth 18.62%
- Profit Growth 16.43%
- Ebitda -173.54%
- Net Worth 16.55%
- Total Assets -1.57%
About Lewis Bioserch Pharma
Lewis Bioserch Pharma Private Limited (LBPPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 March 2012 and has a history of 12 years and ten months. Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹5.00 M.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100CH2012PTC033656
-
Company No.
033656
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Mar 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
What products or services does Lewis Bioserch Pharma Private Limited offer?
Lewis Bioserch Pharma Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, PCD Pharma Franchise, Pharmaceutical Third Party Manufacturing, Pharma Franchise, Allopathic PCD Pharma Franchise, Antacid Drugs, Rabeprazole Tablets, Pharmaceutical Tablets, Herbal Capsules, Ginseng Pills.
Who are the key members and board of directors at Lewis Bioserch Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Na Arti
|
Director | 21-Jan-2023 | Current |
|
Deepak Thakral
|
Director | 22-Mar-2012 | Current |
Financial Performance of Lewis Bioserch Pharma.
Lewis Bioserch Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 18.62% increase. The company also saw a substantial improvement in profitability, with a 16.43% increase in profit. The company's net worth Soared by an impressive increase of 16.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lewis Bioserch Pharma?
Unlock access to Lewis Bioserch Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹5.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jul 2023 | Hdfc Bank Limited | ₹5.00 M | Open |
How Many Employees Work at Lewis Bioserch Pharma?
Unlock and access historical data on people associated with Lewis Bioserch Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lewis Bioserch Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lewis Bioserch Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
